DMAA Drugs Made In America Acquisition Corp. - Ordinary Shares
$10,65
Harga · Jul 2, 2026
Fundamental per Apr 15, 2026
Rentang 52M
$10–$11
100% of range
Peringkat Analis
—
Target Harga
—
P/E (TTM)
—
ROE
-82.4%
Margin Laba Bersih
—
DMAA Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$10.65
Kapitalisasi Pasar
$111M
P/E (TTM)
—
EPS (TTM)
—
Pendapatan (TTM)
—
Imbal Hasil Dividen
—
ROE
-82.4%
D/E Utang/Ekuitas
—
Rentang 52M
$10 – $11
DMAA Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
—
EPS
—
Arus Kas Bebas
—
Margin
—
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
DMAA
Median Rekan
P/B
-15.3
0.9
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
DMAA
Median Rekan
ROA
4.9%
3.1%
ROE
-82.4%
3.9%
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
DMAA
Median Rekan
Current Ratio (Rasio Lancar)
0.0
1.8
Quick Ratio (Rasio Cepat)
0.0
—
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
DMAA
Median Rekan
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
DMAA
Median Rekan
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Laporan Berikutnya
Agu 03, 2026
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 6
| Metrik | Tren | 2025 |
|---|---|---|
| SG&A Expense | $3M | |
| Operating Income | $-3M | |
| Interest Income | $9M | |
| Other Non-op | $9M | |
| Net Income | $6M | |
| EBITDA | $-3M |
Neraca 12
| Metrik | Tren | 2025 |
|---|---|---|
| Cash & Equivalents | $6.1K | |
| Prepaid Expense | $6.1K | |
| Current Assets | $12.2K | |
| Total Assets | $240M | |
| Accounts Payable | $222.2K | |
| Current Liabilities | $376.2K | |
| Total Liabilities | $7M | |
| Common Stock | $1.1K | |
| Retained Earnings | $-7M | |
| Stockholders' Equity | $-7M | |
| Liabilities + Equity | $240M | |
| Shares Outstanding | 10,717,143 |
Arus Kas 3
| Metrik | Tren | 2025 |
|---|---|---|
| Operating Cash Flow | $-539.2K | |
| Investing Cash Flow | $-231M | |
| Financing Cash Flow | $232M |
Profitabilitas 2
| Metrik | Tren | 2025 |
|---|---|---|
| ROA | 4.9% | |
| ROE | -82.4% |
Likuiditas & Solvabilitas 2
| Metrik | Tren | 2025 |
|---|---|---|
| Current Ratio | 0.0 | |
| Quick Ratio | 0.0 |
Valuasi (TTM) 4
| Metrik | Tren | 2025 |
|---|---|---|
| Net Income TTM | $6M | |
| Market Cap | $111M | |
| P/B | -15.3 | |
| P / Cash Flow | -206.2 |
Laporan Laba Rugi 6
| Metrik | Tren | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| SG&A Expense | $2M | $263.7K | $131.9K | $330.9K | |
| Operating Income | $-2M | $-263.7K | $-131.9K | $-330.9K | |
| Interest Income | $2M | $2M | $2M | $2M | |
| Other Non-op | $2M | $2M | $2M | · | |
| Net Income | $213.0K | $2M | $2M | $1M | |
| EBITDA | · | $-263.7K | $-131.9K | $-330.9K |
Neraca 13
| Metrik | Tren | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $6.1K | $717 | $822 | $923 | |
| Prepaid Expense | $6.1K | $27.5K | $48.9K | $70.1K | |
| Current Assets | $12.2K | $28.2K | $49.7K | $71.0K | |
| Total Assets | $240M | $238M | $235M | $233M | |
| Accounts Payable | $222.2K | · | · | · | |
| Accrued Liabilities | · | $302.6K | $147.5K | $132.5K | |
| Current Liabilities | $376.2K | $456.6K | $301.4K | $347.4K | |
| Total Liabilities | $7M | $7M | $7M | $7M | |
| Common Stock | $1.1K | $1.1K | $1.1K | $1.1K | |
| Retained Earnings | $-7M | $-7M | $-6M | $-6M | |
| Stockholders' Equity | $-7M | $-7M | $-7M | $-7M | |
| Liabilities + Equity | $240M | $238M | $235M | $233M | |
| Shares Outstanding | 10,717,143 | 10,517,143 | 10,517,143 | 10,517,143 |
Arus Kas 3
| Metrik | Tren | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-125.2K | $-56.1K | $-106.7K | $-251.2K | |
| Investing Cash Flow | $0 | $0 | $0 | $-231M | |
| Financing Cash Flow | $130.6K | $56.0K | $106.6K | $231M |
Profitabilitas 2
| Metrik | Tren | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| ROA | · | 1.8% | 1.9% | 1.1% | |
| ROE | · | -59.6% | -64.0% | -35.0% |
Likuiditas & Solvabilitas 2
| Metrik | Tren | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Current Ratio | · | 0.1 | 0.2 | 0.2 | |
| Quick Ratio | · | 0.0 | 0.0 | 0.0 |
Valuasi (TTM) 4
| Metrik | Tren | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Net Income TTM | · | $6M | · | · | |
| Market Cap | · | $108M | $107M | $105M | |
| P/B | · | -14.7 | -15.0 | -14.7 | |
| P / Cash Flow | · | · | · | -419.4 |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Laba Bersih | $6M | — |
Neraca
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Rasio Lancar | 0.0 | — |
| Rasio Cepat | 0.0 | — |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.